1.12 +0.02 (1.74%)
CPRX
| Trade CPRX now with |
Stock Details
Last Trade:1.12 Change:+0.02 (1.74%) Prev Close:1.10 Open: 1.15 Days Range:1.11 – 1.15 52 Week Range: 0.90 - 2.25 Volume:20745 P/E: N/AEPS:-0.23
View AllRecent Alerts 02/09/12
Recent Alert on 12/20/11 at 10:45am
Shares of Catalyst Pharma (CPRX) resume trading up 14%
Shares of Catalyst Pharma (CPRX) resume trading up 14%
Shares of Catalyst Pharma (Nasdaq: CPRX) resume trading up 14%
Recent Alert on 12/20/11 at 10:17am
Catalyst Pharma (CPRX) Investigational Drug CPP-115 Gets FDA Fast-Track Designation
Catalyst Pharma (CPRX) Investigational Drug CPP-115 Gets FDA Fast-Track Designation
Recent Alert on 12/20/11 at 10:17am
Catalyst Pharma (CPRX) Investigational Drug CPP-115 Gets FDA Fast-Track Designation
Catalyst Pharma (CPRX) Investigational Drug CPP-115 Gets FDA Fast-Track Designation
Recent Alert on 12/20/11 at 10:17am
Catalyst Pharma (CPRX) Investigational Drug CPP-115 Gets FDA Fast-Track Designation
Catalyst Pharma (CPRX) Investigational Drug CPP-115 Gets FDA Fast-Track Designation
View AllRecent Press Releases
View AllRecent SEC Filings
SEC Filing on 02/09/12 at 2:23pm
Form SC 13G/A CATALYST PHARMACEUTICAL Filed by: FEDERATED INVESTORS INC /PA/
Form SC 13G/A CATALYST PHARMACEUTICAL Filed by: FEDERATED INVESTORS INC /PA/
View AllRecent Blog Posts
Blog Posts on 01/25/12 at 2:38pm
Update On The Trials Of Catalyst Pharma's CPP-109 In Cocaine Addiction And CPP-115 Pre-Clinical Studies
Update On The Trials Of Catalyst Pharma's CPP-109 In Cocaine Addiction And CPP-115 Pre-Clinical Studies
Blog Posts on 01/24/12 at 7:31am
Catalyst Pharma: Awaiting Key Clinical Trial Results For CPP-109 For Treating Cocaine Addiction
Catalyst Pharma: Awaiting Key Clinical Trial Results For CPP-109 For Treating Cocaine Addiction


